However, we did analyze the expression of previously reported FLC RNA markers, PCSK113, 14, 15 and AGR227, and found that together they do differentiate the six DNAJB1-PRKACA expression tumors from all HCC and CCA samples (Supplementary Fig. S2). Here, PRKACA is linked to cholangiocarcinoma.